Elite Pharmaceuticals Inc (ELTP)

[palob]

Consolidated revenues for Fiscal 2016 were a record $12.5 million, an increase of approximately 150% over revenues of the prior year. This increase is due to across-the-board increases in both manufacturing revenues and license fees. Manufacturing revenues more than doubled from $3.8 million last year to $8.0 million in Fiscal 2016. The growth was from a strong, sustained and broad expansion in the sales of Elite's product revenues. License fees more than tripled from $1.1 million last year to $4.5 million in Fiscal 2016

http://ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=81846&GoTopage=1&Category=2163&BzID=2258&t=2054&G=939